Pall Life Sciences
Trending Articles
Related Content
Manufacturing
Delivering an effective COVID-19 vaccine at record speed
COVID-19 is not the first pandemic that we’ve faced but, based on its ease and speed of transmission, it’s certainly one of the most threatening that we’ve experienced in recent history. Many countries have suffered long lockdowns; and, although we’re slowly seeing a loosening of restrictions in some areas, a safe and effective vaccine will be a crucial element in most national “exit strategies” for COVID-19
Manufacturing
Biopharmaceuticals: Integrated automation for downstream processing
John Welsh, Senior Manager at Pall Biotech, on why the biopharma industry must develop its own technology, the challenges to overcome, and efforts underway to offer seamless continuous bioproduction throughout a process
Manufacturing
Lessons for the biopharma sector on automation, analytics and embracing Industry 4.0
The pharmaceutical industry is undergoing a rapid transformation, with biopharmaceuticals now representing the market’s fastest-growing subsector and increasing treatment options for patients, reports Loe Cameron, Director of Analytics and Controls, Pall Corporation
Manufacturing
Pall and Broadley-James to deliver next generation single-use sensor technologies to the life science market
Pall, a global leader in filtration, separation and purification, has partnered with Broadley-James Corporation, a renowned sensor technology provider, to integrate and distribute Broadley-James’ advanced single-use probe and flow cell pH sensors